Ticker Update
What Are The Current Reasons For Raising Akero Therapeutics (AKRO) Pre-Market?
In pre-market trading, shares of Akero Therapeutics Inc. (Nasdaq: AKRO) were up 77.67% to $21.80 after encouraging clinical trial data were announced. In Monday’s session, AKRO stock gained 4.78% to close at $12.27 with 0.68 million shares changing hands. AKRO has shared what? Today, Akero
